The archive · Consumer Apps · Product decision · 2026
Temple: Deepinder Goyal's $54M friends-and-family bet on head-worn health wearables
Zomato co-founder's stealth wearable raises $54M at $190M, doubles to $375M before launch; head-worn 'Entropy' tracker heads for end-2026 pre-orders.
Temple
What the business is
A stealth wearable startup building a pebble-sized device worn on the temple that non-invasively tracks cerebral blood flow, oxygenation, cognitive load and a proprietary 'Entropy' metabolic metric.
Starting capital：$54M friends-and-family seed at ~$190M post-money (Feb 2026)
How it started
After Zomato's listing, Goyal began working on a wearable meant to measure what wrist trackers don't — brain-level physiology. The project surfaced publicly when he wore the device on the Figuring Out podcast, and social media turned the unknown gadget into a viral mystery. In February 2026 Temple raised $54 million from friends and family at a post-money valuation of roughly $190 million; per reports, investors included Peak XV Partners, Steadview Capital, Dharana Capital and Info Edge Ventures, plus more than 80 individual investors and over 30 employees.
What happened
Temple describes the device as a head-worn wearable that tracks cerebral blood flow, oxygenation, cognitive load and a proprietary metric called 'Entropy' — an index from 1 to 250 updated every second. In July 2026 a secondary transaction valued Temple at $375 million, nearly double the seed valuation, and Goyal told employees the company had seen investor interest near $500 million. Temple partnered with Ethereal Machines and Zetwerk for manufacturing, with an expected retail price of roughly ₹75,000–80,000 including lifetime software access and adhesive tapes.
No ending yet — it is still running.
Background
Temple is Deepinder Goyal's post-Zomato bet that a head-worn wearable can open a new category in performance technology. The device is designed to sit against the temple and non-invasively measure cerebral blood flow, oxygenation, cognitive load and a proprietary 'Entropy' metric — an index updated every second that Temple says reflects real-time physiological and metabolic state, data wrist-based wearables do not capture.
The startup first became public when Goyal wore the unidentified gadget on the Figuring Out podcast, turning it into a viral mystery before any marketing. In February 2026 Temple raised $54 million from friends and family at a post-money valuation of roughly $190 million; reports name Peak XV Partners, Steadview Capital, Dharana Capital and Info Edge Ventures among backers, alongside more than 80 individuals and over 30 employees.
In July 2026 a secondary transaction valued Temple at $375 million, nearly double the seed valuation, with Goyal telling employees investor interest had reached nearly $500 million. Temple expects to ship a limited launch edition before the end of 2026 at a reported price of ₹75,000–80,000, positioning itself firmly in the premium health-tech market. Skepticism has grown alongside the hype: neurologists quoted in Indian media cautioned that the device's health measurements are not medically validated.
What has to be true
- Goyal's fame and the podcast mystery gave Temple a national audience before it had a product page, compressing the marketing cost of a hardware launch.
- The round's friends-and-family structure let insiders from Zomato's early days back a high-risk consumer-hardware bet on founder conviction alone.
- The device targets a measurable gap — wrist wearables track the body, not the brain — and pairs it with premium pricing and elite-athlete positioning.
- Secondary demand at $375M before launch shows capital was pricing founder reputation and category novelty, not shipped units.
What can be applied
A founder's mystique can manufacture demand before a product ships — but health claims invite scrutiny, so the launch must prove the data, not just the hype.
Aftermath
As of September 2026, Temple has not yet shipped a product. Goyal says a redesigned version is less than half the size of earlier prototypes, pre-orders for a limited launch edition are due to open, and shipments are expected before the end of 2026. The company is working with Ethereal Machines and Zetwerk on manufacturing; the launch will test whether consumers will pay roughly ₹75,000–80,000 for a device whose health claims remain unvalidated.
Sources
- Deepinder Goyal's Startup 'Temple' Nearly Doubles Valuation
- Deepinder Goyal Temple Device: What is it, how it works, expected Rs 75,000-80,000 price and launch date
spotted an error? The archive wants to know.
Your turn
You just read one. Describe what you are building, and see who is betting on the same thing.
Free account · 3 free questions · no card